Genovis
Genovis empowers the biopharmaceutical and research industries by offering innovative tools that accelerate the development of novel treatments and diagnostics. Our flagship SmartEnzymes™ are designed for ease-of-use and rapid performance, optimizing both analytical and preparative workflows for complex biopharmaceuticals. In addition, our proprietary GlyCLICK® technology enables precise, site-specific IgG conjugation, streamlining the creation of antibody-drug conjugates (ADCs) without the need for antibody engineering.
With extensive experience in supporting customers involved in ADC development and a dedicated custom conjugation service, Genovis supports scientists and researchers worldwide. Our innovative enzyme solutions and cutting-edge technologies are essential in the characterization, development, production, and quality control of biological drugs, advancing the future of healthcare.
